{
  "created_at": "Thu Jul 08 22:59:25 +0000 2021",
  "id_str": "1413267620996976641",
  "full_text": "Pfizer plans to seek U.S. authorization for a Covid-19 booster shot and is developing an updated vaccine that better targets the Delta variant https://t.co/QV1z9tKvpF",
  "display_text_range": [
    0,
    166
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/QV1z9tKvpF",
        "expanded_url": "https://on.wsj.com/3hVRJvc",
        "display_url": "on.wsj.com/3hVRJvc",
        "indices": [
          143,
          166
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 37,
  "favorite_count": 105,
  "possibly_sensitive": false,
  "original_created_at": "Thu Jul 08 22:43:52 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ファイザー社は、Covid-19ブースターショットの米国での承認を申請する予定であり、Deltaバリアントをよりよく標的とした最新のワクチンを開発しています。https://t.co/QV1z9tKvpF"
    },
    {
      "locale": "zh",
      "full_text": "辉瑞公司计划为Covid-19加强针寻求美国授权，并正在开发一种更新的疫苗，更好地针对Delta变体https://t.co/QV1z9tKvpF。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "輝瑞公司計劃爲Covid-19加強針尋求美國授權，並正在開發一種更新的疫苗，更好地針對Delta變體https://t.co/QV1z9tKvpF。"
    }
  ]
}